Recent Blogs

Pegfilgrastim-pbbk injection, for Subcutaneous Use (Fylnetra®) HCPCS Code Q5130 - Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg: Billing Guidelines

Monday, July 17, 2023

Aripiprazole Extended-release Injectable Suspension, for Intramuscular Use (Abilify Asimtufii®) HCPCS Code J3490 - Unclassified Drugs: Billing Guidelines

Monday, July 17, 2023

July Tailored Care Management Provider Manual Updates

Monday, July 17, 2023

Bevacizumab-adcd Injection, for Intravenous Use (Vegzelma®) HCPCS Code Q5129 - Injection, Bevacizumab-adcd (vegzelma), Biosimilar, 10 mg: Billing Guidelines

Monday, July 17, 2023

Public Comment on Innovation Waiver Draft Application Ends July 30

Friday, July 14, 2023

Rates Increased for Obstetrical Maternal Services

Friday, July 14, 2023

Preadmission Screening Resident Review Level II and Local Contact Agency Vendor Transitions

Friday, July 14, 2023

SPECIAL BULLETIN COVID-19 #268: COVID-19 Testing, Vaccination and Counseling Coverage After the Federal Public Health Emergency

Friday, July 14, 2023

REMINDER: Service Visit Location Field Required for all Electronic Visit Verification (EVV) Visits

Tuesday, July 11, 2023

Credit Balance Report Update

Tuesday, July 11, 2023

Tailored Plan Implementation Delayed

Tuesday, July 11, 2023

Making Care Primary Model Provider Update – July 3, 2023

Monday, July 03, 2023